Zoetis Q4 2023 revenue $2.2B (+8%), adj. EPS $1.24; FY2024 guidance $9.075-9.225B

Zoetis Inc.

2023-FY EPS reported $5.07 revenue$8,544,000,000

Q4 revenue $2.2B (+8% reported & operational); net income $525M ($1.14 diluted EPS), up 14% and 15% respectively.
Adjusted net income Q4 $569M ($1.24 diluted EPS), up 6% operational.
FY 2023 revenue $8.5B (+6% reported, +7% operational); net income $2.3B ($5.07 diluted EPS).
FY 2024 guidance: revenue $9.075-9.225B (operational growth 7-9%); adjusted diluted EPS $5.74-5.84.
Key growth drivers: Librela, Simparica Trio, dermatology; new approvals for Solensia in Brazil and Simparica Trio in China.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

Zoetis Inc. reported full year 2023 results: revenue $8.5 Billion, net income $2.3 Billion, EPS $5.07 per Diluted Share. Guidance initiated.

Period: full year 2023
Revenue: $8.5 Billion
Net income: $2.3 Billion
EPS: $5.07 per Diluted Share
Guidance: initiated
Result: reported results

Exact text from the filing

For Full Year 2023, Zoetis Reports Revenue of $8.5 Billion, Growing 6%, and Net Income of $2.3 Billion, or $5.07 per Diluted Share, Increasing 11% and 13%, Respectively, on a Reported Basis

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

Zoetis Inc. reported full year 2024 results: revenue $9.075 - $9.225 Billion, EPS $5.34 to $5.44 on a Reported Basis, or $5.74 to $5.84 on an Adjusted Basis. Guidance initiated.

Period: full year 2024
Revenue: $9.075 - $9.225 Billion
EPS: $5.34 to $5.44 on a Reported Basis, or $5.74 to $5.84 on an Adjusted Basis
Guidance: initiated
Result: guidance update

Exact text from the filing

Provides Full Year 2024 Revenue Guidance of $9.075 - $9.225 Billion, with Diluted EPS of $5.34 to $5.44 on a Reported Basis, or $5.74 to $5.84 on an Adjusted Basis

View on SEC.gov

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

Zoetis Inc. reported the fourth quarter and full year 2023 results: revenue $2.2 billion, net income $525 million, EPS $1.14 per diluted share. Guidance initiated.

Period: the fourth quarter and full year 2023
Revenue: $2.2 billion
Net income: $525 million
EPS: $1.14 per diluted share
Guidance: initiated
Result: reported results

Exact text from the filing

Zoetis Reports Fourth Quarter and Full Year 2023 Results • For Fourth Quarter 2023, Zoetis Reports Revenue of $2.2 Billion, Growing 8%, and Net Income of $525 Million, or $1.14 per Diluted Share, Increasing 14% and 15%, Respectively, on a Reported Basis

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

Zoetis Inc. filing history →

Source: SEC EDGAR

accession 0001555280-24-000141

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.